PointState Capital LP Sells Shares of Roivant Sciences Ltd.
PointState Capital LP reduced its stake in Roivant Sciences Ltd. (NASDAQ:ROIV) by 19.7% in the fourth quarter, according to its most recent filing with the SEC. The fund sold 810,403 shares, leaving it with 3,297,449 shares. This represents 0.7% of PointState Capital LP's portfolio, making Roivant Sciences its 28th largest holding, valued at $39,009,000.
Other institutional investors have also adjusted their positions. Barclays PLC increased its holdings by 19.7% in the third quarter, now owning 459,521 shares valued at $5,302,000. Elevate Capital Advisors LLC initiated a new position in the fourth quarter, valued at approximately $2,116,000. Thompson Siegel & Walmsley LLC increased their stake by 10.1% in the fourth quarter, holding 565,337 shares valued at $6,688,000. Russell Investments Group Ltd. significantly raised its position by 478.6% in the fourth quarter, now owning 2,355 shares valued at $28,000. Raymond James Financial Inc. also established a new position in Roivant Sciences during the fourth quarter, worth approximately $995,000. Overall, institutional investors and hedge funds hold 64.76% of the company's stock.
Several equities analysts have commented on Roivant Sciences (ROIV). HC Wainwright reaffirmed a
